Elevation Oncology Stock

Elevation Oncology Debt 2024

Elevation Oncology Debt

-19.12 USD

Ticker

ELEV

ISIN

US28623U1016

In 2024, Elevation Oncology's total debt was -19.12 USD, a 15.87% change from the -16.5 USD total debt recorded in the previous year.

Elevation Oncology Aktienanalyse

What does Elevation Oncology do?

Elevation Oncology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Elevation Oncology's Debt Structure

Elevation Oncology's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Elevation Oncology's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Elevation Oncology’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Elevation Oncology’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Elevation Oncology stock

What is the debt of Elevation Oncology this year?

Elevation Oncology has a debt level of -19.12 USD this year.

What was the debt of Elevation Oncology compared to the previous year?

The debt of Elevation Oncology has increased by 15.87% compared to the previous year increased.

What are the consequences of high debt for investors in Elevation Oncology?

High debt can pose a risk for investors of Elevation Oncology, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Elevation Oncology?

Low debt means that Elevation Oncology has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Elevation Oncology affect the company?

An increase in debt of Elevation Oncology can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Elevation Oncology affect the company?

A reduction in debt of Elevation Oncology can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Elevation Oncology?

Some factors that can influence the debt of Elevation Oncology include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Elevation Oncology so important for investors?

The debts of Elevation Oncology are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Elevation Oncology take to change the debt?

To change the debt, Elevation Oncology can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Elevation Oncology pay?

Over the past 12 months, Elevation Oncology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Elevation Oncology is expected to pay a dividend of 0 USD.

What is the dividend yield of Elevation Oncology?

The current dividend yield of Elevation Oncology is .

When does Elevation Oncology pay dividends?

Elevation Oncology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Elevation Oncology?

Elevation Oncology paid dividends every year for the past 0 years.

What is the dividend of Elevation Oncology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Elevation Oncology located?

Elevation Oncology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Elevation Oncology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Elevation Oncology from 7/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/27/2024.

When did Elevation Oncology pay the last dividend?

The last dividend was paid out on 7/27/2024.

What was the dividend of Elevation Oncology in the year 2023?

In the year 2023, Elevation Oncology distributed 0 USD as dividends.

In which currency does Elevation Oncology pay out the dividend?

The dividends of Elevation Oncology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Elevation Oncology

Our stock analysis for Elevation Oncology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elevation Oncology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.